Latest Insights on India Transthyretin Amyloidosis Market brief 2026: As per Market Research Future analysis, the India transthyretin amyloidosis market size was estimated at $298.98 Million in 2024. The India transthyretin amyloidosis market is projected to grow from 318.95 $ Million in 2025 to 608.95 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.6% during the forecast period 2025 - 2035. What was once considered futuristic is now a practical tool driving efficiency, accuracy, and personalization across the healthcare ecosystem. From diagnostics to patient care, AI is reshaping clinical and operational workflows at scale.Top listed companies are, Alnylam Pharmaceuticals (US), Pfizer (US), Bristol-Myers Squibb (US), Ionis Pharmaceuticals (US), Eisai Co., Ltd. (JP), Amgen Inc. (US), Teva Pharmaceutical Industries Ltd. (IL), Horizon Therapeutics (IE)
SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
SECTION III: QUALITATIVE ANALYSIS
SECTION IV: QUANTITATIVE ANALYSIS
SECTION V: COMPETITIVE ANALYSIS
Avail Latest Insights on Healthcare Reports: www.marketresearchfuture.com/reports/india-transthyretin-amyloidosis-market-56019
Artificial Intelligence (AI) in healthcare is rapidly transforming how medical services are delivered, managed, and experienced.
Other Related Reports:
Graves Disease Treatment Market
Intravascular Optical Coherence Tomography Imaging System Market
Heatstroke Treatment Market
Athletes Foot Treatment Market
Central Pain Syndrome Management Market
Clinical Chemistry Enzyme Market
Dermal Toxicity Testing Market
Focal Segmental Glomerulosclerosis Treatment Market